FDA Import Refusal BGK-9228461-2/10003/1 — Abbvie Corporation
The FDA refused shipment BGK-9228461-2/10003/1 from Abbvie Corporation (Canada) on Oct 29, 2025. The refused product falls under Drugs and Biologics — CARBOXYMETHYLCELLULOSE SODIUM, EMOLLIENT,LUBRICANT. Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Oct 29, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 64DAK01 CARBOXYMETHYLCELLULOSE SODIUM, EMOLLIENT,LUBRICANT
- Charges
- 118,3280,75